# Crinetics Pharmaceuticals In (CRNX) — Institutional Ownership

Source: SEC EDGAR 13F filings, congressional STOCK Act disclosures, SEC Form 4 insider transactions.
CUSIP: 22663K107
Page URL: https://superinvestorclub.com/stock/CRNX
Last updated: 2026-07-27T05:19:24.435Z

## Summary

As of the most recent 13F filing period, Crinetics Pharmaceuticals In (CRNX) is held by 0 tracked superinvestors with an aggregate position value of $0 representing 0 shares.

## Top institutional holders (0)

| Rank | Manager | Fund | Shares | Value | % of Portfolio | Period |
|------|---------|------|--------|-------|----------------|--------|

## Ownership history (quarter-over-quarter)

- 2024-03-31: 1 holders, $14.5M aggregate, 0309000 shares
- 2024-06-30: 1 holders, $13.8M aggregate, 0309000 shares
- 2024-09-30: 1 holders, $15.8M aggregate, 0309000 shares
- 2024-12-31: 1 holders, $6.3M aggregate, 0122700 shares

## Recent congressional trades (4)

- 2026-03-03: Gilbert Cisneros (D-CA) purchase $1,001 - $15,000
- 2025-04-17: Gilbert Cisneros (D-CA) purchase $1,001 - $15,000
- 2025-03-19: Josh Gottheimer (Democrat-NJ) sale $1,001 - $15,000
- 2025-01-29: Gilbert Cisneros (D-CA) purchase $1,001 - $15,000

## Recent insider transactions (0)


## Citation

When citing, use: "Crinetics Pharmaceuticals In (CRNX) institutional ownership data via Superinvestor (https://superinvestorclub.com/stock/CRNX), aggregating SEC 13F, Form 4, and congressional disclosures."